These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6111334)

  • 21. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced platelet serotonergic responsivity as assessed by dense granule secretion in first-episode psychosis.
    Reddy RD; Keshavan MS; Yao JK
    Clin Biochem; 2007 Sep; 40(13-14):1081-3. PubMed ID: 17601524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blunted serotonergic responsivity in neuroleptic-naïve patients at first-episode of schizophrenia.
    Reddy R; Keshavan M; Yao JK
    Schizophr Res; 2007 Feb; 90(1-3):81-5. PubMed ID: 17204398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Centrifugal and anticoagulant induced variations in platelet rich plasma and their influence on platelet aggregation.
    Healy DT; Egan EL
    Scand J Haematol; 1984 May; 32(5):452-6. PubMed ID: 6729396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the equine platelet aggregation response.
    Meyers KM; Lindner C; Grant B
    Am J Vet Res; 1979 Feb; 40(2):260-4. PubMed ID: 464363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte adhesiveness/aggregation and neuroleptic drug treatment.
    Zemishlany Z; Aizenberg D; Baruch Y; Aronson M
    Int Clin Psychopharmacol; 1991; 6(2):111-5. PubMed ID: 1683666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.
    Lingjaerde O
    Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet [3H]dopamine uptake is differentially affected by neuroleptic drug treatment in schizophrenia and schizophreniform disorder.
    Dean B; Sundram S; Hill C; Copolov DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jan; 20(1):45-55. PubMed ID: 8861176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual effects of 5-hydroxytryptamine on stable analogue of thromboxane A2-induced aggregation and release reaction in rabbit platelets.
    Li BY; Zhou YC; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):171-4. PubMed ID: 10374646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to neuroleptic drugs as a device for classifying schizophrenia.
    Brown WA; Herz LR
    Schizophr Bull; 1989; 15(1):123-9. PubMed ID: 2566199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY; Bai Y; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Hydroxytryptamine-2A receptor gene (HTR 2 A) candidate polymorphism (T 102 C): Role for human platelet function under pharmacological challenge ex vivo.
    Ozdener F; Gülbas Z; Erol K; Ozdemir V
    Methods Find Exp Clin Pharmacol; 2005; 27(6):395-400. PubMed ID: 16179957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
    Tune LE; Creese I; Depaulo JR; Slavney PR; Coyle JT; Snyder SH
    Am J Psychiatry; 1980 Feb; 137(2):187-90. PubMed ID: 6101524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites.
    Boullin DJ; Grahame-Smith DG; Grimes RP; Woods HF
    Br J Pharmacol; 1975 Jan; 53(1):121-5. PubMed ID: 1125484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the magnetic field of a magnetic stirrer in an optical aggregometer affect concurrent platelet aggregation?
    Sagdilek E; Sebik O; Celebi G
    Bioelectromagnetics; 2013 Jul; 34(5):349-57. PubMed ID: 23436227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y 1 and P2Y 12 Receptors.
    Wu CC; Tsai FM; Chen ML; Wu S; Lee MC; Tsai TC; Wang LK; Wang CH
    Biomed Res Int; 2016; 2016():2532371. PubMed ID: 27069920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergism interaction between arachidonic acid by 5-hydroxytryptamine in human platelet aggregation is mediated through multiple signalling pathways.
    Saeed SA; Rasheed H; Gilani AU
    Acta Pharmacol Sin; 2003 Oct; 24(10):958-64. PubMed ID: 14531936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of alcohol withdrawal on responses of platelets from alcoholics--a study using platelet-rich plasma from blood anticoagulated with D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone (FPRCH2Cl).
    Rand ML; Neiman J; Jakowec DM; Packham MA
    Thromb Haemost; 1990 Apr; 63(2):178-82. PubMed ID: 2363118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High sodium intake increases platelet aggregation in normal females.
    Gow IF; Padfield PL; Reid M; Stewart SE; Edwards CR; Williams BC
    J Hypertens Suppl; 1987 Dec; 5(5):S243-6. PubMed ID: 3481816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.